Numan
United Kingdom
- London, England
- 07/02/2022
- Series B
- $60,100,000
We're on a mission to fix ill health for men where they feel it most. It’s a decades-old problem: men aren’t seeking the healthcare that they need. Our survey revealed that 4 out of 10 men haven’t visited a doctor in over a year, and 1 out of 10 can’t even remember the last time they saw a doctor. We help solve the issues that men often leave untreated - not the life-threatening stuff, but the kinds of health problems that can be swept under the rug and may not be outwardly visible.
We're a digital health platform for men - providing access to expert advice, medication, diagnostics and supplements.
At Numan, we help men do something about their health, and live longer, healthier lives.
- Industry Wellness and Fitness Services
- Website https://www.numan.com/
- LinkedIn https://www.linkedin.com/company/numan-com/about/
Related People
Sokratis PapafloratosFounder
United Kingdom -
London, England
Technology entrepreneur and angel investor.
Pinnacle Medicines | $89,000,000 | (Mar 27, 2026)
CurrentClient | $1,250,000 | (Mar 27, 2026)
Mirage | $75,000,000 | (Mar 27, 2026)
Scalvy | $13,900,000 | (Mar 27, 2026)
SIGMAS | $1,000,000 | (Mar 27, 2026)
VITL | $7,500,000 | (Mar 27, 2026)
Payy | $6,000,000 | (Mar 27, 2026)
Conntour | $7,000,000 | (Mar 27, 2026)
KilgourMD | Undisclosed Amount | (Mar 27, 2026)
Terrestrial | $50,000,000 | (Mar 27, 2026)
Krane | $9,000,000 | (Mar 26, 2026)
Zalos (YC F25) | $3,600,000 | (Mar 26, 2026)